{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:57:49Z","timestamp":1770062269591,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T00:00:00Z","timestamp":1577232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0424\u043e\u043d\u0434 \u0424\u0443\u043d\u0434\u0430\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u044b\u0445 \u0418\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439 (\u0420\u0424\u0424\u0418)","award":["17-54-30015-\u041d\u0418\u0417_\u0430"],"award-info":[{"award-number":["17-54-30015-\u041d\u0418\u0417_\u0430"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Despite the achievements of antiretroviral therapy, discovery of new anti-HIV medicines remains an essential task because the existing drugs do not provide a complete cure for the infected patients, exhibit severe adverse effects, and lead to the appearance of resistant strains. To predict the interaction of drug-like compounds with multiple targets for HIV treatment, ligand-based drug design approach is widely applied. In this study, we evaluated the possibilities and limitations of (Q)SAR analysis aimed at the discovery of novel antiretroviral agents inhibiting the vital HIV enzymes. Local (Q)SAR models are based on the analysis of structure\u2013activity relationships for molecules from the same chemical class, which significantly restrict their applicability domain. In contrast, global (Q)SAR models exploit data from heterogeneous sets of drug-like compounds, which allows their application to databases containing diverse structures. We compared the information for HIV-1 integrase, protease and reverse transcriptase inhibitors available in the EBI ChEMBL, NIAID HIV\/OI\/TB Therapeutics, and Clarivate Analytics Integrity databases as the sources for (Q)SAR training sets. Using the PASS and GUSAR software, we developed and validated a variety of (Q)SAR models, which can be further used for virtual screening of new antiretrovirals in the SAVI library. The developed models are implemented in the freely available web resource AntiHIV-Pred.<\/jats:p>","DOI":"10.3390\/molecules25010087","type":"journal-article","created":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T11:07:48Z","timestamp":1577272068000},"page":"87","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-8350","authenticated-orcid":false,"given":"Leonid A.","family":"Stolbov","sequence":"first","affiliation":[{"name":"Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry, 10 bldg. 8, Pogodinskaya str., 119121 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry S.","family":"Druzhilovskiy","sequence":"additional","affiliation":[{"name":"Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry, 10 bldg. 8, Pogodinskaya str., 119121 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry A.","family":"Filimonov","sequence":"additional","affiliation":[{"name":"Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry, 10 bldg. 8, Pogodinskaya str., 119121 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Nicklaus","sequence":"additional","affiliation":[{"name":"Computer-Aided Drug Design Group, Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-2621","authenticated-orcid":false,"given":"Vladimir V.","family":"Poroikov","sequence":"additional","affiliation":[{"name":"Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry, 10 bldg. 8, Pogodinskaya str., 119121 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Yella, J.K., Yaddanapudi, S., Wang, Y., and Jegga, A.G. (2018). Changing trends in computational drug repositioning. Pharmaceuticals (Basel), 11.","DOI":"10.20944\/preprints201805.0011.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.1096361","article-title":"The many roles of computation in drug discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Phillips, M.A., Stewart, M.A., Woodling, D.L., and Xie, Z.-R. (2018). Has molecular docking ever brought us a medicine. Molecular Docking, IntechOpen.","DOI":"10.5772\/intechopen.72898"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tarasova, O., Poroikov, V., and Veselovsky, A. (2018). Molecular docking studies of HIV-1 resistance to reverse transcriptase inhibitors: Mini-review. Molecules, 23.","DOI":"10.3390\/molecules23051233"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/ja01062a035","article-title":"Ro-sigma\u2013pi analysis. A method for the correlation of biological activity and chemical structure","volume":"86","author":"Hancsh","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/jm00334a001","article-title":"A mathematical contribution to structure-activity studies","volume":"7","author":"Free","year":"1964","journal-title":"J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Franke, R. (1984). Theoretical Drug Design Methods, Akademie\u2014Verlag.","DOI":"10.1515\/9783112706992"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1039\/C8SC00148K","article-title":"Large-scale comparison of machine learning methods for drug target prediction on ChEMBL","volume":"9","author":"Mayr","year":"2018","journal-title":"Chem. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/7355_2015_5001","article-title":"Anti-HIV Agents: Current Status and Recent Trends","volume":"29","author":"Geronikaki","year":"2016","journal-title":"Top. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/1568026615666150813150433","article-title":"Novel HIV-1 integrase inhibitor development by virtual screening based on QSAR models","volume":"16","author":"Guasch","year":"2016","journal-title":"Cur. Top. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/1062936X.2018.1529702","article-title":"Finding the structural requirements of diverse HIV-1 protease inhibitors using multiple QSAR modelling for lead identification","volume":"29","author":"Halder","year":"2018","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hdoufane, I., Bjij, I., Soliman, M., Tadjer, A., Villemin, D., Bogdanov, J., and Cherqaoui, D. (2018). In silico SAR studies of HIV-1 inhibitors. Pharmaceuticals (Basel), 13.","DOI":"10.3390\/ph11030069"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2014.03.013","article-title":"QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method","volume":"77","author":"Toropova","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","unstructured":"(2019, October 19). Synthetically Accessible Virtual Inventory, Available online: https:\/\/cactus.nci.nih.gov\/download\/savi_download\/."},{"key":"ref_16","unstructured":"(2019, October 19). REAL Compounds Library. Available online: https:\/\/www.enaminestore.com\/products\/real-compounds."},{"key":"ref_17","unstructured":"(2019, October 19). NIAID HIV\/OI\/TB Therapeutics Database, Available online: https:\/\/chemdb.niaid.nih.gov\/."},{"key":"ref_18","unstructured":"(2019, October 19). European Bioinformatics Institute ChEMBL Database. Available online: https:\/\/www.ebi.ac.uk\/chembl\/."},{"key":"ref_19","unstructured":"(2019, October 19). Clarivate Analytics Integrity Database. Available online: https:\/\/integrity.clarivate.com\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1021\/acs.jcim.6b00129","article-title":"Trust, but verify II: A practical guide to chemogenomics data curation","volume":"56","author":"Fourches","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acs.jcim.5b00019","article-title":"QSAR Modeling using large-scale databases: case study for HIV-1 reverse transcriptase inhibitors","volume":"55","author":"Tarasova","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nikitina, A.A., Orlov, A.A., Kozlovskaya, L.I., Palyulin, V.A., and Osolodkin, D.I. (2019). Enhanced taxonomy annotation of antiviral activity data from ChEMBL. Database (Oxford), bay139.","DOI":"10.1093\/database\/bay139"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Comp."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/10629360903438370","article-title":"QNA based \u201cStar Track\u201d QSAR approach","volume":"20","author":"Filimonov","year":"2009","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pogodin, P.V., Lagunin, A.A., Rudik, A.V., Druzhilovskiy, D.S., Filimonov, D.A., and Poroikov, V.V. (2019). AntiBac-Pred: A web portal for predicting antibacterial activity of chemical compounds. J. Chem. Inform. Model.","DOI":"10.1021\/acs.jcim.9b00436"},{"key":"ref_26","unstructured":"(2019, October 19). AntiHIV-Pred. Available online: http:\/\/www.way2drug.com\/hiv\/."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stolbov, L., Druzhilovskiy, D., Rudik, A., Filimonov, D., Poroikov, V., and Nicklaus, M. (2019). AntiHIV-Pred: Web-resource for in silico prediction of anti-HIV\/AIDS activity. Bioinformatics.","DOI":"10.1093\/bioinformatics\/btz638"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/acs.jcim.9b00164","article-title":"Data mining approach for extraction of useful information about biologically active compounds from publications","volume":"59","author":"Tarasova","year":"2019","journal-title":"J. Chem. Inform. Model."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best Practices for QSAR Model Development, Validation, and Exploitation","volume":"12","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/ci980335o","article-title":"Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors","volume":"39","author":"Filimonov","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/87\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:45:34Z","timestamp":1760190334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["molecules25010087"],"URL":"https:\/\/doi.org\/10.3390\/molecules25010087","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,25]]}}}